Summaries of the Section H (HML) update
Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.
The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.
The changes will be published in the Online HML(external link) around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.
17 April 2025 - preview of changes for May 2025
|
Pharmaceutical |
Change |
|---|---|
|
Adalimumab (Humira – Alternative brand) inj 20 mg per 0.2 ml prefilled syringe (Huimra), inj 40 mg per 0.4 ml prefilled syringe (Humira) and inj 40 mg per 0.4 ml prefilled pen (HumiraPen) |
decrease price |
|
Atazanavir sulphate (Atazavanir Mylan) cap 150 mg |
to be delisted on 1 November 2025 |
|
Atorvastatin (Lipitor) tab 20 mg |
delisted 1 May 2025 |
|
Atorvastatin (Lorstat) tab 80 mg, 30 pack |
to be delisted 1 November 2025 |
|
Azacitidine (Azacitidine Dr Reddy’s) inj 100 mg vial |
amended restriction criteria |
|
Bacillus Calmette-Guerin (BCG) (SII-Onco-BCG) inj 40 mg per ml, vial |
new listing (p’code 2474239) |
|
Bupivacaine hydrochloride with fentanyl (Biomed) inj 1.25 mg with fentanyl 2 mcg per ml, 15 ml syringe |
delisted 1 May 2025 |
|
Casirivimab with imdevimab (Ronapreve) inj 120 mg per ml casirivimab, 11.1 ml vial (1) and inj 120 mg per ml imdevimab, 11.1 ml vial (1) |
delisted 1 May 2025 |
|
Diatrizoate meglumine with sodium amidotrizoate (Gastrografin Ger, Gastrografin S29) oral liquid 660 mg per ml with sodium amidotrizoate 100 mg per ml, 100 ml bottle |
to be delisted 1 June 2025 |
|
Enteral feed 1 kcal/ml (Nutrison Multi Fibre) liquid 4 g protein, 12.3 g carbohydrate, 3.9 g fat and 1.5 g fibre per 100 ml, 1,000 ml bottle |
new listing (p’code 2703270) |
|
Enteral feed 1 kcal/ml (Nutrison Multi Fibre) liquid 4 g protein, 12.3 g carbohydrate, 3.9 g fat and 1.5 g fibre per 100 ml, 1,000 ml bottle |
to be delisted 1 January 2026 (p’code 2702428) |
|
Enteral feed 1 kcal/ml (Nutrison RTH) liquid 4 g protein, 12.4 g carbohydrate and 3.9 g fat per 100 ml, 1,000 ml bottle |
new listing (p’code 2703262) |
|
Enteral feed 1 kcal/ml (Nutrison RTH) liquid 4 g protein, 12.3 g carbohydrate and 3.9 g fat per 100 ml, 1,000 ml bottle |
to be delisted 1 January 2026 (p’code 2702118) |
|
Enteral feed 1.5 kcal/ml (Nutrison Energy) liquid 6 g protein, 18.5 g carbohydrate and 5.8 g fat per 100 ml, 1,000 ml bottle |
new listing (p’code 2703289) |
|
Enteral feed 1.5 kcal/ml (Nutrison Energy) liquid 6 g protein, 18.3 g carbohydrate and 5.8 g fat per 100 ml, 1,000 ml bottle |
to be delisted 1 January 2026 (p’code 2702355) |
|
Enteral feed 1.5 kcal/ml (Nutrison Energy Multi Fibre) liquid 6 g protein, 18.4 g carbohydrate, 5.8 g fat and 1.5 g fibre per 100 ml, 1,000 ml bottle |
new listing (p’code 2703297) |
|
Enteral feed 1.5 kcal/ml (Nutrison Energy Multi Fibre) liquid 6 g protein, 18.4 g carbohydrate, 5.8 g fat and 1.5 g fibre per 100 ml, 1,000 ml bottle |
to be delisted 1 January 2026 (p’code 2702452) |
|
Fentanyl (Biomed) inj 10 mg per ml, 50 ml bag and 50 ml syringe |
delisted 1 May 2025 |
|
Fentanyl (Fentanyl Sandoz) patch 12 mcg per hour |
new presentation listing (p’code 2688824) and addition of PSS |
|
Fentanyl (Fentanyl Sandoz) patch 12.5 mg per hour |
to be delisted on 1 November 2025 and removal of PSS |
|
Fluticasone propionate (Flixonase Hayfever & Allergy) metered dose nasal spray, 50 mcg per dose |
increase price, addition of PSS and amended presentation |
|
Gentamicin sulphate (Gentamicin Hikma) inj 10 mg per ml, 2 ml ampoule |
new listing (p’code 2705435) |
|
Hyoscine hydrobromide (Scopolamine Transdermal System Viatris) patch 1 mg per 72 hours |
amended brand name |
|
Ibrutinib (Imbruvica) tab 140 mg and 420 mg |
amended restriction criteria |
|
Insulin degludec with insulin aspart (Ryzodeg 70/30 Penfill) inj degludec 70 u with insulin aspart 30 u, 100 u per ml, 3 ml |
new listing (p’code 2704471) |
|
Itraconazole (Itraconazole Cresent) cap 100 mg |
new listing (p’code 2705109) |
|
Morphine sulphate (Biomed) inj 2 mg per ml, 30 ml syringe |
delisted 1 May 2025 |
|
Niraparib (Zejula) cap 100 mg, 84 pack |
to be delisted 1 July 2025 |
|
Nitazoxanide (Alinia) tab 500 mg |
delisted 1 May 2025 (brand only) |
|
Phytomenadione (Konakion MM) inj 2 mg in 0.2 ml ampoule |
new Pharmacode listing (p’code 2703572) |
|
Promethazine hydrochloride (Phenergan Elixir) oral liq 1 mg per ml, 100 ml |
to be delisted 1 July 2025 |
|
Secukinumab (Cosentyx) inj 150 mg per ml, 1 ml prefilled syringe |
amended restriction criteria |
|
Solifenacin succinate (Solifenacin Viatris) tab 5 mg |
increase price and delist delayed until 1 November 2025 |
|
Upadacitinib (Rinvoq) |
amended presentation description
new listing
|
|
Upadacitinib (Rinvoq) tab modified release 15mg, 30 mg and 45 mg |
amended restriction criteria |
|
Venetoclax (Venclexta) tab 14 × 10 mg, 7 × 50 mg, 21 × 100 mg, 10 mg, 50 mg and 100 mg |
amended restriction criteria |